STOCK TITAN

Aveanna Healthcare Holdings (AVAH) Financials

AVAH NASDAQ
Trailing 12 months to October 3, 2026
Revenue $2.7B +16.8% YoY
Net Income $306.1M +305.7% YoY
EPS (Diluted) $1.40 +278.4% YoY
Operating Cash Flow $207.2M +131.4% YoY
Market Cap $2.5B as of Nov 16, 2026
Price / Sales 0.9x on $2.7B revenue, trailing 12 months to October 3, 2026
Price / Earnings 8.3x on $306.1M net income, trailing 12 months to October 3, 2026
Price / Book 7.5x on $337.4M equity, Q3 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Nov 16, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q3 FY2026, ended Oct 3, 2026 Reported Currency USD FYE January

Newest figures come from the 10-Q for Q3 FY2026, filed Nov 12, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the AVAH SEC filings page.

Aveanna Healthcare Holdings Inc. (AVAH) reported $2.7B in revenue over the twelve months to Oct 3, 2026, up 16.8% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 7 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI AVAH FY2026

Aveanna’s operating turnaround is real, but cash conversion remains incomplete and substantial leverage still shapes how the business is financed.

From FY2024 to FY2026, operating income increased 83.5% while interest expense fell 10.5%, showing that improved operations reached below the operating line without eliminating financing drag. Net income of $225M versus operating cash flow of $126M means reported profit was not yet translating dollar-for-dollar into cash.

Gross margin rose 1.9 percentage points to 33.3% by FY2026. SG&A fell to 15.4% of revenue from 17.4% in FY2024, indicating the profit improvement came from both gross economics and overhead absorption.

Assets grew 21.0% from FY2024 to FY2026 while liabilities grew only 1.8%, indicating asset growth was not funded mainly by adding liabilities. At FY2026, the current ratio was 1.3 while debt-to-equity was 6.6x, showing better near-term coverage alongside substantial leverage.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 44 / 100
Financial Health Score (5 of 6 dimensions) 44/100

Scored against operating companies for FY2026. Each of the six dimensions is a percentile rank within that peer group, and the overall is the average of the dimensions that can be computed: here 5 of 6, with the others left out rather than counted as zero. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Aveanna Healthcare Holdings Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
42

Profitability ranks operating companies on their operating margin with gains on asset sales taken out, averaged over the last three fiscal years with the newest counting most, and in smaller part on how steady that margin has been. Aveanna Healthcare Holdings Inc. scores 42/100 on it among other operating companies.

Growth
72

Growth ranks operating companies on the yearly rate at which revenue compounded across the last three fiscal years (the last two where the earliest reports no revenue), counted in the currency each company reports in so that a move in the exchange rate is not read as growth. Aveanna Healthcare Holdings Inc. scores 72/100 on it among other operating companies.

Leverage
20

Aveanna Healthcare Holdings Inc.'s net debt of $1.1B, being $1.3B of long-term debt less $193.3M of cash, came to 4.10 times its EBITDA in fiscal year 2026. Operating companies are ranked here on long-term debt less cash against their EBITDA, where a lower multiple is the safer one, and Aveanna Healthcare Holdings Inc. scores 20/100 among other operating companies measured the same way.

Liquidity
36

Aveanna Healthcare Holdings Inc. held $1.32 of current assets for every $1 of current liabilities at the end of fiscal year 2026, a current ratio of 1.32. Liquidity ranks operating companies on that ratio, and Aveanna Healthcare Holdings Inc. scores 36/100 among other operating companies.

Cash Flow
n/a

Not available for Aveanna Healthcare Holdings Inc., so it is left out of the overall score, which averages the 5 of 6 dimensions that can be computed.

Returns
51

Returns ranks operating companies on their return on capital employed, which is operating income against total assets less current liabilities, averaged over three fiscal years with the newest weighted most, and in smaller part on how steady that return has been. Aveanna Healthcare Holdings Inc. scores 51/100 on it among other operating companies.

Altman Z-Score Distress
1.74

Aveanna Healthcare Holdings Inc. scores 1.74, below the 1.81 distress threshold. The score is pulled down most by an accumulated deficit of $1.2B against total assets of $2.0B. This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Neutral
6/9

Aveanna Healthcare Holdings Inc. passes 6 of 9 financial strength tests. 3 of 4 profitability signals pass, 2 of 3 leverage/liquidity signals pass, 1 of 2 operating efficiency signals passes.

Earnings Quality Mixed
0.56x

For every $1 of reported earnings, Aveanna Healthcare Holdings Inc. generates $0.56 in operating cash flow ($125.9M OCF vs $225.0M net income). This mixed ratio suggests some earnings may rely on non-cash accounting items.

Interest Coverage At Risk
1.83x

Aveanna Healthcare Holdings Inc. earns $1.83 in operating income for every $1 of interest expense ($256.5M vs $140.1M). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$695.5M
YoY+11.8%
QoQ+3.7%
5Y CAGR+11.1%

Aveanna Healthcare Holdings Inc. generated $695.5M in revenue in Q3 2026. This represents an increase of 11.8% from the same quarter a year earlier. Against the prior quarter it is up 3.7%.

EBITDA
$86.7M
YoY+54.4%
QoQ+4.7%
5Y CAGR+29.8%

Aveanna Healthcare Holdings Inc.'s EBITDA was $86.7M in Q3 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 54.4% from the same quarter a year earlier. Against the prior quarter it is up 4.7%.

Net Income
$45.5M
YoY+223.2%
QoQ+12.8%
5Y CAGR+85.1%

Aveanna Healthcare Holdings Inc. reported $45.5M in net income in Q3 2026. This represents an increase of 223.2% from the same quarter a year earlier. Against the prior quarter it is up 12.8%.

EPS (Diluted)
$0.20
YoY+233.3%
QoQ+11.1%

Aveanna Healthcare Holdings Inc. earned $0.20 per diluted share (EPS) in Q3 2026. This represents an increase of 233.3% from the same quarter a year earlier. Against the prior quarter it is up 11.1%.

Cash & Balance Sheet

Cash & Debt
$197.8M
YoY+35.6%
QoQ+103.6%
5Y CAGR+10.2%

Aveanna Healthcare Holdings Inc. held $197.8M in cash against $1.3B in long-term debt as of Q3 2026.

Shares Outstanding
218M
YoY+4.5%
QoQ+0.1%
5Y CAGR+3.5%

Aveanna Healthcare Holdings Inc. had 218M shares outstanding in Q3 2026. This represents an increase of 4.5% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Free Cash Flow

Not reported for Q3 2026.

Dividends Per Share

Not reported for Q3 2026.

Margins & Returns

Gross Margin
32.6%
YoY0.0pp
QoQ0.0pp
5Y change-1.4pp

Aveanna Healthcare Holdings Inc.'s gross margin was 32.6% in Q3 2026, indicating the percentage of revenue retained after direct costs. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Operating Margin
12.0%
YoY+3.4pp
QoQ+0.1pp
5Y change+7.5pp

Aveanna Healthcare Holdings Inc.'s operating margin was 12.0% in Q3 2026, reflecting core business profitability. This is up 3.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.1 percentage points.

Net Margin
6.5%
YoY+4.3pp
QoQ+0.5pp
5Y change+6.0pp

Aveanna Healthcare Holdings Inc.'s net profit margin was 6.5% in Q3 2026, showing the share of revenue converted to profit. This is up 4.3 percentage points from the same quarter a year earlier. Against the prior quarter it is up 0.5 percentage points.

Return on Equity
13.5%
YoY-139.7pp
QoQ-0.6pp

Aveanna Healthcare Holdings Inc.'s quarterly ROE was 13.5% in Q3 2026: one quarter's net income over shareholder equity, not annualized. This is down 139.7 percentage points from the same quarter a year earlier. Against the prior quarter it is down 0.6 percentage points.

Capital Allocation

None of these metrics is reported for Q3 2026.

AVAH Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AVAH quarterly income statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Revenue$695.5M+11.8%$670.5M+13.7%$647.9M+15.9%$662.5M+27.4%$621.9M+22.2%$589.6M+16.8%$559.2M+14.0%$519.9M+8.6%
Cost of Revenue$468.8M+11.8%$452.0M+19.3%$442.5M+17.8%$449.2M+29.0%$419.1M+20.0%$378.8M+9.2%$375.7M+9.0%$348.1M+5.4%
Gross Profit$226.8M+11.8%$218.5M+3.7%$205.4M+11.9%$213.3M+24.2%$202.8M+27.0%$210.8M+33.2%$183.6M+25.9%$171.7M+15.7%
SG&A Expenses$103.5M+8.5%$97.1M+7.8%$95.8M+4.8%$97.6M+10.0%$95.4M+8.2%$90.1M+2.4%$91.4M+4.0%$88.7M+2.0%
Operating Income$83.6M+55.9%$80.0M-0.1%$69.3M+33.8%$71.0M+55.2%$53.6M+57.5%$80.0M+115.6%$51.8M+126.5%$45.8M+56.3%
EBITDA$86.7M+54.4%$82.8M+0.2%$72.4M+33.0%$73.8M+53.0%$56.2M+53.5%$82.7M+106.8%$54.4M+111.0%$48.2M+48.0%
Interest Expense$27.1M-22.9%$27.8M-22.9%$29.2M-19.8%$32.6M-14.4%$35.1M-10.5%$36.0M-9.1%$36.3M-8.4%$38.1M-4.0%
Income Tax$19.3Mn/m$16.2M-5.5%$3.3M-33.0%-$139.5Mn/m-$647K-104.2%$17.1Mn/m$5.0M-60.9%-$2.2Mn/m
Net Income$45.5M+223.2%$40.3M+49.1%$41.7M+702.1%$178.8M+512.6%$14.1Mn/m$27.0M+94.3%$5.2Mn/m$29.2Mn/m
EPS (Basic)$0.21+200.0%$0.19+46.2%$0.19+533.3%$0.88+486.7%$0.07n/m$0.13+85.7%$0.03n/m$0.15n/m
EPS (Diluted)$0.20+233.3%$0.18+38.5%$0.19+533.3%$0.83+453.3%$0.06n/m$0.13+85.7%$0.03n/m$0.15n/m
Diluted Shares (Avg)229M+3.1%225M+6.9%222M+7.7%N/A222M+14.9%210M+6.9%206M+7.3%N/A

Not reported in any period shown, so not listed: R&D Expenses.

AVAH Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AVAH quarterly balance sheet
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Total Assets$2.2B+21.9%$2.1B+18.9%$2.0B+21.8%$2.0B+21.0%$1.8B+10.1%$1.8B+6.4%$1.7B+1.1%$1.7B+3.1%
Current Assets$565.9M+12.6%$478.1M+6.3%$575.3M+41.1%$560.2M+42.7%$502.6M+31.8%$449.9M+23.6%$407.6M+21.3%$392.7M+24.7%
Cash & Equivalents$197.8M+35.6%$97.2M-3.5%$189.3M+164.7%$193.3M+129.3%$145.9M+85.9%$100.7M+111.4%$71.5M+67.8%$84.3M+91.8%
Short-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Accounts Receivable$333.7M+6.7%$337.2M+6.6%$332.7M+12.8%$313.4M+18.2%$312.8M+17.8%$316.3M+15.9%$294.8M+14.5%$265.2M+12.1%
Long-Term Investments$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m$0n/m
Goodwill$1.3B+14.6%$1.3B+14.1%$1.1B+6.3%$1.1B+6.3%$1.1B+5.9%$1.1B+6.1%$1.1B0.0%$1.1B0.0%
Total Liabilities$1.9B+3.8%$1.8B+2.0%$1.8B+1.2%$1.8B+1.8%$1.8B+0.1%$1.8B0.0%$1.8B-1.0%$1.8B+2.6%
Current Liabilities$460.3M+12.4%$411.3M-0.7%$390.4M+0.5%$424.5M+5.5%$409.7M+0.9%$414.2M+6.4%$388.3M+1.7%$402.2M+13.4%
Non-Current Liabilities$1.4B+1.2%$1.4B+2.9%$1.4B+1.4%$1.4B+0.7%$1.4B-0.2%$1.4B-1.8%$1.4B-1.7%$1.4B-0.2%
Long-Term Debt$1.3B-0.6%$1.3B+1.2%$1.3B+1.1%$1.3B+1.2%$1.3B+1.1%$1.3B-0.3%$1.3B-0.4%$1.3B-0.4%
Total Equity$337.4M+3573.9%$287.3Mn/m$240.1Mn/m$194.5Mn/m$9.2Mn/m-$12.0Mn/m-$100.1Mn/m-$123.6Mn/m
Retained Earnings-$1.0Bn/m-$1.1Bn/m-$1.1Bn/m-$1.2Bn/m-$1.3Bn/m-$1.3Bn/m-$1.4Bn/m-$1.4Bn/m

Not reported in any period shown, so not listed: Inventory.

AVAH Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AVAH quarterly cash flow statement
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Operating Cash Flow$72.2M+117.6%$80.9M+56.9%$4.3Mn/m$49.7M+270.9%$33.2M+12.9%$51.6M+2750.7%-$8.6Mn/m$13.4Mn/m
Depreciation & Amortization$3.2M+21.8%$2.8M+8.9%$3.0M+17.3%$2.7M+11.5%$2.6M+0.5%$2.6M-7.6%$2.6M-10.9%$2.4M-25.5%
Stock-Based CompensationN/AN/A$4.1M-62.3%N/AN/AN/A$11.0M+169.4%N/A
Investing Cash Flow-$8.8Mn/m-$175.4Mn/m-$4.6Mn/m-$1.9Mn/m-$2.0Mn/m-$16.0Mn/m-$2.3Mn/m-$1.5Mn/m
Financing Cash Flow$37.2M+166.4%$2.4Mn/m-$3.8Mn/m-$377Kn/m$13.9M+285.3%-$6.3M-240.5%-$1.8M-115.2%-$6.1M-2838.0%

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow, Dividends Paid, Share Buybacks.

AVAH Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

AVAH quarterly financial ratios
MetricQ3'2610-QQ2'2610-QQ1'2610-QQ4'2510-KQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-K
Gross Margin32.6%0.0pp32.6%-3.2pp31.7%-1.1pp32.2%-0.8pp32.6%+1.2pp35.8%+4.4pp32.8%+3.1pp33.0%+2.0pp
Operating Margin12.0%+3.4pp11.9%-1.7pp10.7%+1.4pp10.7%+1.9pp8.6%+1.9pp13.6%+6.2pp9.3%+4.6pp8.8%+2.7pp
Net Margin6.5%+4.3pp6.0%+1.4pp6.4%+5.5pp27.0%+21.4pp2.3%+10.7pp4.6%+1.8pp0.9%+3.2pp5.6%+11.0pp
Return on Equity13.5%-139.7pp14.0%17.3%91.9%153.1%N/AN/AN/A
Return on Assets2.1%+1.3pp1.9%+0.4pp2.1%+1.8pp8.9%+7.1pp0.8%+3.4pp1.5%+0.7pp0.3%+1.0pp1.8%+3.4pp
Current Ratio1.230.0x1.16+0.1x1.47+0.4x1.32+0.3x1.23+0.3x1.09+0.2x1.05+0.2x0.98+0.1x
Debt-to-Equity3.80-136.6x4.475.356.62140.39N/AN/AN/A
Liabilities-to-Equity5.54-190.5x6.337.429.34196.05N/AN/AN/A
Asset Turnover0.320.0x0.320.0x0.320.0x0.330.0x0.340.0x0.330.0x0.340.0x0.310.0x

Not reported in any period shown, so not listed: FCF Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it. Market cap is stated at each company's latest close.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Aveanna Healthcare Holdings Inc. AVAH FY2026 $2.4B $225.0M 9.3% $2.5B 44/100
Pediatrix Medical Group, Inc. MD FY2025 $1.9B $165.4M 8.6% $2.5B 44/100
Ardent Health, Inc. ARDT FY2025 $6.3B $135.8M 2.1% $2.6B 54/100
Addus HomeCare Corp. ADUS FY2025 $1.4B $95.9M 6.7% $2.3B 68/100
Brookdale Senior Living, Inc. BKD FY2025 $3.2B -$262.7M -8.2% $2.1B 24/100
Surgery Partners, Inc. SGRY FY2025 $3.3B -$77.9M -2.4% $3.5B 54/100

Frequently Asked Questions

Aveanna Healthcare Holdings Inc. (AVAH) reported $2.4B in total revenue for fiscal year 2026. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

Yes, Aveanna Healthcare Holdings Inc. (AVAH) reported a net income of $306.1M over the trailing 12 months to October 3, 2026. In fiscal year 2026 it reported a net income of $225.0M, with a net profit margin of 9.3%.

Aveanna Healthcare Holdings Inc. (AVAH) reported diluted earnings per share of $1.05 for fiscal year 2026. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Aveanna Healthcare Holdings Inc. (AVAH) had EBITDA of $267.0M in fiscal year 2026, measuring earnings before interest, taxes, depreciation, and amortization.

As of fiscal year 2026, Aveanna Healthcare Holdings Inc. (AVAH) had $193.3M in cash and equivalents against $1.3B in long-term debt.

Aveanna Healthcare Holdings Inc. (AVAH) had a gross margin of 33.3% in fiscal year 2026, indicating the percentage of revenue retained after direct costs of goods sold.

Aveanna Healthcare Holdings Inc. (AVAH) had an operating margin of 10.5% in fiscal year 2026, reflecting the profitability of core business operations before interest and taxes.

Aveanna Healthcare Holdings Inc. (AVAH) had a net profit margin of 9.3% in fiscal year 2026, representing the share of revenue converted into profit after all expenses.

Aveanna Healthcare Holdings Inc. (AVAH) has a return on equity of 115.7% for fiscal year 2026, measuring how efficiently the company generates profit from shareholder equity.

Aveanna Healthcare Holdings Inc. (AVAH) generated $125.9M in operating cash flow during fiscal year 2026, representing cash generated from core business activities.

Aveanna Healthcare Holdings Inc. (AVAH) had $2.0B in total assets as of fiscal year 2026, including both current and long-term assets.

Aveanna Healthcare Holdings Inc. (AVAH) had 218M shares outstanding as of fiscal year 2026.

Aveanna Healthcare Holdings Inc. (AVAH) had a current ratio of 1.32 as of fiscal year 2026, which is considered adequate.

Aveanna Healthcare Holdings Inc. (AVAH) had a debt-to-equity ratio of 6.62 as of fiscal year 2026. We compute it as long-term debt divided by total shareholder equity, where long-term debt is the noncurrent part of the company's borrowings, so debt due within the next twelve months is not counted.

Aveanna Healthcare Holdings Inc. (AVAH) had a liabilities-to-equity ratio of 9.34 as of fiscal year 2026, which is total liabilities divided by total shareholder equity. Total liabilities counts every obligation on the balance sheet (payables, deposits, insurance reserves and deferred taxes as well as borrowings), so this ratio usually runs well above debt-to-equity.

Aveanna Healthcare Holdings Inc. (AVAH) had a return on assets of 11.2% for fiscal year 2026, measuring how efficiently the company uses its assets to generate profit.

Aveanna Healthcare Holdings Inc. (AVAH) trades at 8.3x earnings, its market capitalization divided by $306.1M net income, trailing 12 months to October 3, 2026. The market capitalization is $2.5B as of Nov 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Aveanna Healthcare Holdings Inc. (AVAH) trades at 0.9x sales, its market capitalization divided by $2.7B revenue, trailing 12 months to October 3, 2026. The market capitalization is $2.5B as of Nov 16, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

Aveanna Healthcare Holdings Inc. (AVAH) has an Altman Z-Score of 1.74, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

Aveanna Healthcare Holdings Inc. (AVAH) has a Piotroski F-Score of 6 out of 9, indicating neutral financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Aveanna Healthcare Holdings Inc. (AVAH) has an earnings quality ratio of 0.56x, considered mixed quality. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Aveanna Healthcare Holdings Inc. (AVAH) has an interest coverage ratio of 1.83x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

Aveanna Healthcare Holdings Inc. (AVAH) scores 44 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is the average of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. For Aveanna Healthcare Holdings Inc. it averages the 5 of 6 dimensions that can be computed; the others are left out rather than counted as zero. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top